PEMGX | PMVRX | PEMGX / PMVRX | |
Total Expense Ratio | 0.91 | 1.30 | 70% |
Annual Report Gross Expense Ratio | 0.91 | 1.30 | 70% |
Fund Existence | 20 years | 22 years | - |
Gain YTD | 7.790 | 3.269 | 238% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 32.9B | 375M | 8,773% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 8.27 | -7.27 | -114% |
Returns for 3 years | 41.97 | 22.12 | 190% |
Returns for 5 years | 45.47 | -14.47 | -314% |
Returns for 10 years | 108.17 | 3.63 | 2,983% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLBR | 17.81 | 0.06 | +0.33% |
Franklin FTSE Brazil ETF | |||
LFSC | 27.67 | N/A | N/A |
F/m Emerald Life Sciences Innovation ETF | |||
VCSH | 79.69 | -0.08 | -0.10% |
Vanguard Short-Term Corporate Bond ETF | |||
AHYB | 46.66 | -0.06 | -0.12% |
American Century® Select High Yield ETF | |||
FFLC | 50.72 | -0.22 | -0.43% |
Fidelity Fundamental Large Cap Core ETF |